{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:31:46Z","timestamp":1780680706055,"version":"3.54.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2013.11.025","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T11:01:08Z","timestamp":1385895668000},"page":"780-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions"],"prefix":"10.1016","volume":"132","author":[{"given":"Clare J.","family":"Reade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lua R.","family":"Eiriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.11.025_bb0005","series-title":"SEER Cancer Statistics Review, 1975\u20132009 (Vintage 2009 Populations)","author":"Howlader","year":"2012"},{"issue":"5","key":"10.1016\/j.ygyno.2013.11.025_bb0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/IGC.0b013e318249bce6","article-title":"Trends in treatment and survival of late-stage squamous cell vulvar carcinomas: analysis of the surveillance, epidemiology, and end results (SEER) database","volume":"22","author":"Ramanah","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0015","series-title":"Principles and Practice of Gynecologic Oncology","first-page":"555","article-title":"Chapter 20: vulva","author":"Moore","year":"2009"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0020","first-page":"574","article-title":"Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions","volume":"58","author":"Hacker","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.11.025_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/IGC.0b013e3181996ac3","article-title":"Patterns of care for radiotherapy in vulvar cancer: a gynecologic cancer intergroup study","volume":"19","author":"Gaffney","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0035","doi-asserted-by":"crossref","first-page":"PL19","DOI":"10.1136\/ijgc-00009577-200303001-00019","article-title":"Randomised study between neoadjuvant chemoradiotherapy and primary surgery for the treatment of advanced vulval cancer","volume":"13","author":"Maneo","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0045","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00762-8","article-title":"Preoperative chemo-radiation for carcinoma of the vulva with N2\/N3 nodes: a gynecologic oncology group study","volume":"48","author":"Montana","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IGC.0b013e31824b4058","article-title":"Weekly paclitaxel\/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer","volume":"22","author":"Han","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2005.06.068","article-title":"Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration","volume":"100","author":"Geisler","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0090-8258(90)90367-T","article-title":"Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)","volume":"37","author":"Durrant","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.2001.6180","article-title":"Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer","volume":"81","author":"Wagenaar","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0070","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0b013e318263ef55","article-title":"Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study","volume":"22","author":"Aragona","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0090-8258(91)90345-6","article-title":"Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva","volume":"42","author":"Berek","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0080","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(00)00569-1","article-title":"Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva","volume":"47","author":"Han","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2010.09.004","article-title":"Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3\u20134-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva","volume":"120","author":"Mak","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0095","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0360-3016(80)90246-1","article-title":"A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck","volume":"6","author":"Parsons","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-8258(89)90157-1","article-title":"Concurrent radiation and chemotherapy in vulvar carcinoma","volume":"34","author":"Thomas","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ygyno.2004.03.019","article-title":"Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma","volume":"93","author":"Mulayim","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ygyno.2004.09.016","article-title":"Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases","volume":"96","author":"Bellati","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0090-8258(86)90138-1","article-title":"Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study","volume":"23","author":"Thigpen","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00000421-198904000-00011","article-title":"Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study","volume":"12","author":"Muss","year":"1989","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000259259","article-title":"Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma","volume":"77","author":"Cormio","year":"2009","journal-title":"Oncology (Williston)"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0130","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdp043","article-title":"Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer\u2014Gynaecological Cancer Group)","volume":"20","author":"Witteveen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0135","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.pas.0000213251.82940.bf","article-title":"p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. [article]","volume":"30","author":"Santos","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ygyno.2008.01.041","article-title":"New aspects of vulvar cancer: changes in localization and age of onset","volume":"109","author":"Hampl","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0145","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.humpath.2004.09.004","article-title":"p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias","volume":"35","author":"Riethdorf","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0150","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/ijc.23446","article-title":"Risk factors for invasive squamous cell carcinoma of the vulva and vagina\u2014population-based case-control study in Denmark","volume":"122","author":"Madsen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/LGT.0b013e3182472947","article-title":"Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction","volume":"16","author":"Gargano","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0160","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ygyno.2003.11.052","article-title":"Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma","volume":"92","author":"Pinto","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0170","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/PAS.0b013e3180686d10","article-title":"Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination","volume":"31","author":"Skapa","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0175","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.1229934","article-title":"Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins","volume":"339","author":"Zanier","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0180","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1158\/1078-0432.CCR-07-4760","article-title":"Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia","volume":"14","author":"Winters","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0185","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/IGC.0b013e3181a388c4","article-title":"Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection","volume":"19","author":"Farhat","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0190","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bjc.6605611","article-title":"Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia","volume":"102","author":"Daayana","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.169.1.350","article-title":"Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides","volume":"169","author":"Zwaveling","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0200","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0205","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMe0907480","article-title":"Human papillomavirus vaccine for cancer prevention","volume":"361","author":"Finn","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0210","series-title":"ASCO Meeting Abstracts","article-title":"Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: a phase III randomized trial of the Gynecologic Oncology Group","volume":"31","author":"Tewari","year":"2013"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2012.06.028","article-title":"Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva","volume":"127","author":"Horowitz","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0220","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1158\/0008-5472.CAN-04-2495","article-title":"Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839","volume":"65","author":"Zanchi","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0225","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ygyno.2007.05.006","article-title":"Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva","volume":"106","author":"Olawaiye","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0230","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1525-1438.2007.01145.x","article-title":"Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab","volume":"18","author":"Richard","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2011.02.035","article-title":"Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib","volume":"306","author":"Luwor","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0240","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1023\/A:1023454107190","article-title":"Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(l-glutamic acid) through a polyethylene glycol spacer","volume":"20","author":"Vega","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0245","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2006.05.036","article-title":"Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 (\u201cIressa\u201d) and trastuzumab (\u201cHerceptin\u201d)","volume":"66","author":"Fukutome","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0250","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15257770802086872","article-title":"Synthesis and biological activity of mustard derivatives of thymine","volume":"27","author":"Hadj-Bouazza","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0255","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.bmc.2005.02.010","article-title":"Design, synthesis and biological evaluation of novel riccardiphenol analogs","volume":"13","author":"Kumar","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0260","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1593\/neo.09662","article-title":"Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model","volume":"11","author":"Hofmann","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0265","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1749-6632.2009.04888.x","article-title":"Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase","volume":"1171","author":"Kim","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0090-8258(86)90060-0","article-title":"The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva","volume":"25","author":"Levin","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0275","first-page":"1029","article-title":"Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project","volume":"35","author":"Carson","year":"1990","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0280","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1471-0528.1990.tb01832.x","article-title":"A pilot study of chemo-radiotherapy in advanced carcinoma of the vulva","volume":"97","author":"Whitaker","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0285","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02841869309092448","article-title":"Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva","volume":"32","author":"Scheistroen","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/gyno.1995.1267","article-title":"Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva","volume":"59","author":"Eifel","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0295","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/gyno.1996.0150","article-title":"Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma","volume":"61","author":"Landoni","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0300","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1472::AID-CNCR8>3.0.CO;2-E","article-title":"Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study","volume":"77","author":"Lupi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0305","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2005.07.126","article-title":"Preoperative chemoradiation for locally advanced carcinoma of the vulva","volume":"99","author":"Gerszten","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2007.10.026","article-title":"Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma","volume":"109","author":"Beriwal","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.11.025_bb0315","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3892\/ol.2012.831","article-title":"Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva","volume":"4","author":"Gaudineau","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/gyno.1993.1163","article-title":"Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma","volume":"50","author":"Benedetti-Panici","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0325","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/01443610410001685547","article-title":"Carcinoma of the vulva: a retrospective review of 37 cases at a regional cancer centre in South India","volume":"24","author":"Bafna","year":"2004","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0330","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/IGC.0b013e3181c93adc","article-title":"Neoadjuvant chemotherapy in advanced vulvar cancer","volume":"20","author":"Domingues","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/00016348209156555","article-title":"Irradiation and bleomycin in the treatment of inoperable vulval carcinoma","volume":"61","author":"Iversen","year":"1982","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.1985.3.7.917","article-title":"Effective multimodality treatment for advanced epidermoid carcinoma of the female genital tract","volume":"3","author":"Kalra","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0345","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0360-3016(88)90124-1","article-title":"Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies","volume":"15","author":"Evans","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0350","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0090-8258(92)90068-T","article-title":"Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva","volume":"47","author":"Russell","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0355","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0360-3016(93)90496-I","article-title":"Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer","volume":"26","author":"Koh","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ygyno.2013.11.025_bb0360","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1525-1438.1994.04030150.x","article-title":"Treatment of advanced carcinoma of the vulva with chemoradiotherapy\u2014can exenterative surgery be avoided?","volume":"4","author":"Sebag-Montefiore","year":"1994","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0365","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/1097-0142(19950501)75:9<2289::AID-CNCR2820750917>3.0.CO;2-4","article-title":"Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva","volume":"75","author":"Wahlen","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0370","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1997.4758","article-title":"Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva","volume":"66","author":"Cunningham","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0375","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/gyno.1997.4804","article-title":"Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer","volume":"66","author":"Leiserowitz","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.11.025_bb0380","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0360-3016(00)00593-9","article-title":"Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma","volume":"48","author":"Akl","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0385","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2007.11.010","article-title":"Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation","volume":"108","author":"Landrum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.11.025_bb0390","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/COC.0b013e3181cae6a1","article-title":"The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature","volume":"34","author":"Tans","year":"2011","journal-title":"Am J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813013528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813013528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T04:58:31Z","timestamp":1564894711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813013528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825813013528"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.11.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}